These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38560689)

  • 1. Integrative analysis of bulk and single-cell RNA-seq reveals the molecular characterization of the immune microenvironment and oxidative stress signature in melanoma.
    Li Y; Jiang B; Chen B; Zou Y; Wang Y; Liu Q; Song B; Yu B
    Heliyon; 2024 Mar; 10(6):e28244. PubMed ID: 38560689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
    Mi K; Zeng L; Chen Y; Yang S
    Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
    Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
    J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer.
    Tan Z; Chen X; Zuo J; Fu S; Wang J; Wang H
    J Inflamm Res; 2023; 16():3399-3417. PubMed ID: 37600224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.
    Ding Y; Zhao Z; Cai H; Zhou Y; Chen H; Bai Y; Liu Z; Liu S; Zhou W
    Front Immunol; 2023; 14():1304466. PubMed ID: 38077400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis.
    Guo H; Zhang L; Su H; Yang J; Lei J; Li X; Zhang S; Zhang X
    Heliyon; 2024 Sep; 10(18):e38014. PubMed ID: 39347397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.
    Guo Y; Liu N
    J Oncol; 2022; 2022():5388283. PubMed ID: 36090899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
    Zheng M; Hu Y; Liu O; Li S; Wang Y; Li X; Liu J; Yang Q; Li X; Lin B
    Oxid Med Cell Longev; 2023; 2023():1261039. PubMed ID: 36743693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.